BASIS~ (603) 893-3758

WHITEPAPERS

WHITEPAPERS

Whitepapers

Whitepaper: Nitrosamines Analysis

WHITEPAPERS Home / Whitepapers / Nitrosamines Analysis Nitrosamines Analysis Since the FDA’s discovery of nitrosamines impurities, which led to the voluntary recall of valsartan in 2018, the pharmaceutical industry has undertaken a thorough investigation of this class...

read more

Whitepaper: Raw Materials Testing

WHITEPAPERS Raw Materials Testing Raw materials are an important aspect of manufacturing a high-quality product. In pharmaceutical manufacturing, when raw materials are not tested and verified to be the highest quality, inferior drugs can enter the marketplace....

read more